Shanghai Fosun Phamaceutical (Group) Co. Ltd

Shanghai Fosun Pharmaceutical (Group) Co. Ltd is an investment holding company specialising in the production of pharmaceuticals, as well as wholesale and retail business through its subsidiaries and joint ventures. The company is a market leader in liver disease medication, gynocological drugs, diabetes drugs and clinical diagnostic products. Sinopharm Medicine Holding Co. Ltd, in which the company holds a 49% stake, is the largest domestic pharmaceutical distribution enterprise in China and maintains an exclusive national distribution network which commands the largest share of the domestic pharmaceutical market. In addition, the company operates retail pharmacies including Golden Elephant Pharmacy, Fosun Pharmacy, Guoda Pharmacy and Shanghai Pharmacy. As the first domestic direct supplier to the World Health Organization, Guiling Pharmacy Co. Ltd, a subsidiary of the company, has become the largest industrial base for abrotanum production, while its proprietary artesunate tablets have been awarded certification by the World Health Organization.